(Q39178437)

9 September 2017

title

Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis (English)

1 reference

experimental autoimmune encephalomyelitis

9 September 2017

main subject

0 references

mesenchymal stem cell

1 reference

1

0 references

Matthew D Smith

series ordinal

2

0 references

Peter Calabresi

series ordinal

3

object named as

Peter A Calabresi

1 reference

9 September 2017

Katharine A Whartenby

series ordinal

4

object named as

Katharine A Whartenby

1 reference

9 September 2017

language of work or name

1 reference

1 October 2014

1 reference

9 September 2017

1 reference

9 September 2017

volume

32

1 reference

9 September 2017

issue

10

1 reference

9 September 2017

page(s)

2744-2755

1 reference

Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice

9 September 2017

cites work

1 reference

Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure

21 January 2018

1 reference

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

21 January 2018

1 reference

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms

21 January 2018

1 reference

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

21 January 2018

1 reference

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner

21 January 2018

1 reference

Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.

21 January 2018

1 reference

Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor.

21 January 2018

1 reference

Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells

21 January 2018

1 reference

Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models.

21 January 2018

1 reference

Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation.

21 January 2018

1 reference

IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease

21 January 2018

1 reference

Concise review: mesenchymal stem cells and translational medicine: emerging issues.

21 January 2018

1 reference

Mesenchymal stem cell therapy: Two steps forward, one step back

21 January 2018

1 reference

Mesenchymal stem cells: a double-edged sword in regulating immune responses

21 January 2018

1 reference

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

21 January 2018

1 reference

Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation

21 January 2018

1 reference

Multiple sclerosis: T-cell receptor expression in distinct brain regions

21 January 2018

1 reference

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

21 January 2018

1 reference

Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls

21 January 2018

1 reference

Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis

21 January 2018

1 reference

CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1.

21 January 2018

1 reference

Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases.

21 January 2018

1 reference

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

21 January 2018

1 reference

Signal transduction inhibition of APCs diminishes th17 and Th1 responses in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs

21 January 2018

1 reference

21 January 2018

1 reference

Cytokines and the inception of CD8 T cell responses

21 January 2018

1 reference

The IL-23/IL-17 axis in inflammation

21 January 2018

1 reference

Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation

21 January 2018

1 reference

A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity

21 January 2018

1 reference

IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis

21 January 2018

1 reference

Pathogenic CD8 T cells in multiple sclerosis and its experimental models

21 January 2018

1 reference

Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo

21 January 2018

1 reference

Mesenchymal stem cells: mechanisms of inflammation

21 January 2018

1 reference

Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.

21 January 2018

1 reference

CD8(+) T cells: foot soldiers of the immune system

21 January 2018

1 reference

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype

21 January 2018

1 reference

Mesenchymal stromal cells: sensors and switchers of inflammation

21 January 2018

1 reference

Regulation of suppressing and activating effects of mesenchymal stem cells on the encephalitogenic potential of MBP68–86-specific lymphocytes

21 January 2018

1 reference

Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis

21 January 2018

1 reference

Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis

21 January 2018

1 reference

12 December 2020

Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation

1 reference

12 December 2020

Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide

1 reference

12 December 2020

Scaffold-free cell sheet injection results in bone formation

1 reference

12 December 2020

Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells

1 reference

12 December 2020

MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes

1 reference

12 December 2020

Mesenchymal stem cells for acute graft-versus-host disease

1 reference

12 December 2020

Identifiers

DOI

10.1002/STEM.1755

1 reference

9 September 2017

1 reference